Summary
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) on September 17, 2015, primarily serves as a Regulation FD disclosure. The company's officers were scheduled to meet with securities analysts and investors between September 17 and September 30, 2015. During these interactions, Anthem intended to reaffirm its previously issued financial guidance for the full year 2015. The key takeaway for investors is the reiteration of the company's net income guidance. Anthem expected net income to be greater than $9.55 per share, including greater than $0.45 per share in net unfavorable adjustment items. Excluding these specific adjustments, the company projected adjusted net income to exceed $10.00 per share. This reaffirms confidence in the company's near-term financial performance and outlook as presented in its second quarter 2015 earnings release, with no new significant updates or deviations from prior forecasts.
Key Highlights
- 1Anthem, Inc. (now Elevance Health) filed an 8-K on September 17, 2015.
- 2The filing is primarily a Regulation FD disclosure concerning upcoming investor and analyst meetings.
- 3The company reaffirmed its full-year 2015 net income guidance.
- 4Full-year 2015 net income was expected to be greater than $9.55 per share.
- 5Unfavorable adjustment items were projected to be greater than $0.45 per share.
- 6Excluding these adjustments, adjusted net income was expected to be greater than $10.00 per share.
- 7The guidance did not include any adjustments beyond those reported in the Q2 2015 earnings release.